United Surgical Partners International

The future looks promising for ambulatory surgery centers (ASCs) as the health care industry’s focus on cost efficiencies shifts toward where surgical procedures are performed.  Surgeries with increasing complexity, once limited to hospitals, are now shifting to ASCs, indicating continued growth for the foreseeable future. A recent Jefferies equity research report highlighted the structural tailwinds driving this transformation and projected 6% to 8% growth for the ASC sector through … [Read more...]

Ambulatory surgery centers (ASCs) will continue to play a central role in Tenet Healthcare Corp.’s (NYSE: THC) growth strategy. That’s according to Tenet CEO Saum Sutaria, who shared an update on his business and its outpatient surgery arm during a recent investor conference. “The ability to do more things more efficiently and with good outcomes in the ASC setting is clear,” he said.  United Surgical Partners International (USPI), Tenet’s ASC division, is one of the company’s strongest … [Read more...]

Tenet Healthcare Corp. (NYSE: THC) providers – including its ambulatory surgery center (ASC) arm – are suing Blue Cross and Blue Shield of Florida and affiliate Health Options Inc. The suit alleges the insurers underpaid or denied more than $21 million in claims for care provided to insured patients across Florida. That care included both inpatient and outpatient health care services, according to Tenet. Filed July 3 in the 11th Judicial Circuit Court of Florida, the more than 400-page … [Read more...]

Tenet Healthcare Corporation (NYSE: THC) closed out 2024 strong, partly propelled by growth in its large ambulatory surgery center (ASC) division, United Surgical Partners International (USPI). Moving forward, the company is focused on ASC expansion and high-acuity case growth, CEO Saum Sutaria said during the company’s Q4 earnings call. "We intend to invest approximately $250 million each year towards M&A in the ambulatory space,” Sutaria said. “And the pipeline of opportunities … [Read more...]

The 2024 presidential election has ushered in Donald Trump’s return to the White House. With it, questions arise about the future of health care policy and implications for the ambulatory surgery center (ASC) industry. “President Trump was president for four years, so it’s not like we’re walking into this completely blind,” J. Blake Peart, managing director at health care advisory firm Vertess, told ASC News.  The Affordable Care Act (ACA) remains a critical issue, Peart said. During his … [Read more...]

With the potential for regulatory changes on the horizon, particularly regarding antitrust policies, Tenet Healthcare Corporation (NYSE: THC) CEO Saum Sutaria said that a more favorable environment for mergers and acquisitions in the coming years could support further healthcare consolidation.  Such a change would support ambulatory surgery center (ASC) dealmaking, although Sutaria noted that ASC merger and acquisition activity is unlikely to trigger antitrust concerns under any circumstances … [Read more...]

For Tenet Healthcare (NYSE: THC), 2024 has been a “transformative year.” In part, that transformation comes from Tenet making progress on its deleveraging goals by divesting hospital assets, a strategy that will, in turn, free the company up to execute on M&A opportunities and more moving forward. And at the same time, Tenet’s ambulatory surgery center (ASC) business – United Surgical Partners International (USPI) – continues to thrive, propelled by higher-acuity procedures shifting into … [Read more...]